RS111104A - Derivati 1-/(indol-3- il)karbonil/piperazina - Google Patents

Derivati 1-/(indol-3- il)karbonil/piperazina

Info

Publication number
RS111104A
RS111104A YUP-1111/04A YUP111104A RS111104A RS 111104 A RS111104 A RS 111104A YU P111104 A YUP111104 A YU P111104A RS 111104 A RS111104 A RS 111104A
Authority
RS
Serbia
Prior art keywords
indol
carbonyl
methoxy
cyclohexylmethyl
alkyl
Prior art date
Application number
YUP-1111/04A
Other languages
English (en)
Serbian (sr)
Inventor
Philip Martin Cowley
Wilson Caulfield
Jason Tierney
James Cairns
Worrall Julia Adam
Mark York
Original Assignee
Akzo Nobel N.V.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V., filed Critical Akzo Nobel N.V.,
Publication of RS111104A publication Critical patent/RS111104A/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
YUP-1111/04A 2002-06-21 2003-06-13 Derivati 1-/(indol-3- il)karbonil/piperazina RS111104A (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077505 2002-06-21
PCT/EP2003/050226 WO2004000832A1 (en) 2002-06-21 2003-06-13 1-[(indol-3-yl)carbonyl] piperazine derivatives

Publications (1)

Publication Number Publication Date
RS111104A true RS111104A (sr) 2007-02-05

Family

ID=29797228

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-1111/04A RS111104A (sr) 2002-06-21 2003-06-13 Derivati 1-/(indol-3- il)karbonil/piperazina

Country Status (32)

Country Link
US (1) US7304064B2 (enExample)
EP (1) EP1549637B1 (enExample)
JP (1) JP4408804B2 (enExample)
KR (1) KR20050009755A (enExample)
CN (1) CN1298716C (enExample)
AR (1) AR040274A1 (enExample)
AT (1) ATE361290T1 (enExample)
AU (1) AU2003250245B2 (enExample)
BR (1) BR0311960A (enExample)
CA (1) CA2490141C (enExample)
CO (1) CO5680419A2 (enExample)
CY (1) CY1107677T1 (enExample)
DE (1) DE60313640T2 (enExample)
DK (1) DK1549637T3 (enExample)
EC (1) ECSP045503A (enExample)
ES (1) ES2285183T3 (enExample)
HR (1) HRP20041186A2 (enExample)
IL (1) IL165572A0 (enExample)
IS (1) IS2443B (enExample)
MX (1) MXPA04012856A (enExample)
NO (1) NO20045351L (enExample)
NZ (1) NZ537143A (enExample)
PE (1) PE20040578A1 (enExample)
PL (1) PL375152A1 (enExample)
PT (1) PT1549637E (enExample)
RS (1) RS111104A (enExample)
RU (1) RU2318821C2 (enExample)
SI (1) SI1549637T1 (enExample)
TW (1) TW200402417A (enExample)
UA (1) UA78317C2 (enExample)
WO (1) WO2004000832A1 (enExample)
ZA (1) ZA200410057B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
ATE375349T1 (de) 2002-08-02 2007-10-15 Merck & Co Inc Substituierte furo(2,3-b)pyridin derivate
DE10253426B4 (de) * 2002-11-15 2005-09-22 Elbion Ag Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
EP1696930B1 (en) * 2003-12-17 2007-04-11 N.V. Organon Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists
TWI330635B (en) 2004-03-05 2010-09-21 Organon Nv (indol-3-yl)-heterocycle derivatives
EP1904068A1 (en) * 2005-07-11 2008-04-02 N.V. Organon Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist)
BRPI0614692A2 (pt) * 2005-07-29 2009-05-19 Hoffmann La Roche derivados de indol-3-il-carbonil-piperidina e piperazina
TW200745096A (en) * 2005-08-23 2007-12-16 Organon Nv Indole derivatives
US7763732B2 (en) 2005-08-24 2010-07-27 N.V. Organon Indole derivatives
EA200800888A1 (ru) * 2005-09-23 2009-02-27 Янссен Фармацевтика Н.В. Модуляторы каннабиноидов на основе замещенных 3-амидотетрагидроиндазолилов
TW200848417A (en) 2007-02-22 2008-12-16 Organon Nv Indole derivatives
RU2387642C2 (ru) 2007-10-31 2010-04-27 Общество С Ограниченной Ответственностью "Бинатех" Производные 5-замещенных индол-3-карбоновой кислоты, обладающие противовирусной активностью, способ их получения и применение
GB201106817D0 (en) * 2011-04-21 2011-06-01 Astex Therapeutics Ltd New compound
ES2883289T3 (es) 2013-12-20 2021-12-07 Astex Therapeutics Ltd Compuestos heterocíclicos bicíclicos y sus usos en terapia
EP3737680A1 (en) 2018-01-08 2020-11-18 F. Hoffmann-La Roche AG Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors
CN108752342A (zh) * 2018-08-17 2018-11-06 西安瑞联新材料股份有限公司 1-H-吡啶并[1,2-a]-6-氢吡嗪-1,4-二酮的制备方法
CN111100063B (zh) * 2018-10-25 2022-05-17 南京药石科技股份有限公司 一种合成2-氟甲基取代的吡咯烷、哌啶以及哌嗪衍生物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2071529C (en) * 1989-12-28 2001-03-20 Donna Lee Romero Diaromatic substituted anti-aids compounds
WO1998006715A1 (en) 1996-08-09 1998-02-19 Smithkline Beecham Corporation Novel piperazine containing compounds
AU1887401A (en) * 1999-12-14 2001-06-25 Nippon Shinyaku Co. Ltd. Medicinal composition
EP1254115A2 (en) 2000-02-11 2002-11-06 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases

Also Published As

Publication number Publication date
UA78317C2 (en) 2007-03-15
CY1107677T1 (el) 2013-04-18
CO5680419A2 (es) 2006-09-29
DK1549637T3 (da) 2007-07-16
RU2005101349A (ru) 2005-06-27
TW200402417A (en) 2004-02-16
JP4408804B2 (ja) 2010-02-03
IL165572A0 (en) 2006-01-15
ECSP045503A (es) 2005-03-10
AR040274A1 (es) 2005-03-23
CA2490141C (en) 2011-01-25
MXPA04012856A (es) 2005-03-31
US7304064B2 (en) 2007-12-04
ATE361290T1 (de) 2007-05-15
EP1549637A1 (en) 2005-07-06
ES2285183T3 (es) 2007-11-16
AU2003250245A1 (en) 2004-01-06
CA2490141A1 (en) 2003-12-31
JP2005533801A (ja) 2005-11-10
DE60313640D1 (de) 2007-06-14
PL375152A1 (en) 2005-11-28
IS7590A (is) 2004-12-09
RU2318821C2 (ru) 2008-03-10
KR20050009755A (ko) 2005-01-25
CN1668611A (zh) 2005-09-14
ZA200410057B (en) 2005-10-20
NO20045351L (no) 2005-01-20
US20050250760A1 (en) 2005-11-10
CN1298716C (zh) 2007-02-07
DE60313640T2 (de) 2007-12-27
HK1076630A1 (en) 2006-01-20
BR0311960A (pt) 2005-03-22
SI1549637T1 (sl) 2007-10-31
HRP20041186A2 (en) 2005-06-30
PE20040578A1 (es) 2004-09-15
PT1549637E (pt) 2007-05-31
WO2004000832A1 (en) 2003-12-31
NZ537143A (en) 2005-05-27
IS2443B (is) 2008-11-15
AU2003250245B2 (en) 2008-07-03
EP1549637B1 (en) 2007-05-02

Similar Documents

Publication Publication Date Title
RS111104A (sr) Derivati 1-/(indol-3- il)karbonil/piperazina
US6197975B1 (en) Antagonists of gonadotropin releasing hormone
JP2978566B2 (ja) ノイロキニンレセプター拮抗薬としての５−アザビシクロ［３．１．０］ヘキシルアルキル−２−ピペリドンおよび−グルタルイミド
US5607960A (en) Indole derivatives as 5-HT1-like agonists for use in migraine
US20080004306A1 (en) Compositions and methods for modulating gated ion channels
AU7714998A (en) Antagonists of gonadotropin releasing hormone
HRP20010854A2 (en) INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
JP2002535331A (ja) 新規血管形成阻害薬
WO2008148867A2 (en) Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
CN105440032A (zh) 作为enac阻断剂的吡嗪衍生物
CA2337407A1 (en) Antagonists of gonadotropin releasing hormone
CA2630617C (en) Compositions and methods for modulating gated ion channels
AU1124399A (en) Antagonists of gonadotropin releasing hormone
RS51358B (sr) Derivati n-(heteroaril)-1h-indol-2-karboksamida i njihova upotreba kao liganda vaniloidnog trpv1 receptora
JP2013534928A (ja) 新規テトラヒドロキノリン誘導体
EP1581522B1 (en) Flavaxate derivatives as muscarinic receptor antagonists
DD297970A5 (de) Verfahren zur herstellung von be1-(1h-indol-3-yl)-maleinimid-derivaten und deren verwendung
US3361759A (en) 3-(2-pyrrolidinyl)-indoles and method of preparation
HK1076630B (en) 1-(indol-3-yl) carbonyl piperazine derivatives
Welstead et al. Aminoalkylindoles with Central Nervous System Activity
김진형 Synthesis of 2-anilino-4-(imidazo [1, 2-a] pyridin-3-yl)-pyrimidine based Proteolysis Targeting Chimeras (PROTACs) for the degradation of IGF-1R
US3470204A (en) 3-(1-pyrrolin-2-yl)indoles
CN101679385A (zh) 作为nk3受体拮抗剂的脯氨酰胺-四唑衍生物